Pure Global
NCT06373302

Peripheral Arterial Disease Biomarkers

Peripheral Arterial Disease Biomarkers: The Effect of Intervention on Biomarker Levels and Predictors of Restenosis or Deterioration
Norfolk and Norwich University Hospitals NHS Foundation Trust·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Peripheral Arterial Disease
Study type
Observational
Sponsor & location
Primary sponsor
Norfolk and Norwich University Hospitals NHS Foundation Trust
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Dec 31, 2026
Enrollment
100 participants
Primary outcome

Correlation between PAD biomarker levels and walking distance.,Change in PAD biomarker levels following exercise therapy.,Change in PAD biomarker levels following endovascular intervention

Summary

The study aims to determine how expression levels of biomarkers for peripheral arterial
 disease change over time in response to exercise therapy, surgical or endovascular
 intervention, and whether they can be used to predict disease progression.

ICD-10 classifications
Peripheral vascular disease, unspecifiedOther peripheral vascular diseasesOther specified peripheral vascular diseasesPeripheral angiopathy in diseases classified elsewhereOther congenital malformations of peripheral vascular system
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06373302
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06373302 through Pure Global AI's free database. This phase not specified trial is sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust and is currently Not yet recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.